Testing effectiveness (Phase 2)Study completedNCT02878798
What this trial is testing
Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)
Who this might be right for
Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome
Virginia Commonwealth University 132